Cargando…

Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling

Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non...

Descripción completa

Detalles Bibliográficos
Autores principales: Mühlenbeck, Henning, Tsutsui, Yuko, Lemmon, Mark A., Bender, Kyle W., Zipfel, Cyril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473708/
https://www.ncbi.nlm.nih.gov/pubmed/37662281
http://dx.doi.org/10.1101/2023.08.23.554490
_version_ 1785100324022779904
author Mühlenbeck, Henning
Tsutsui, Yuko
Lemmon, Mark A.
Bender, Kyle W.
Zipfel, Cyril
author_facet Mühlenbeck, Henning
Tsutsui, Yuko
Lemmon, Mark A.
Bender, Kyle W.
Zipfel, Cyril
author_sort Mühlenbeck, Henning
collection PubMed
description Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic (pseudo)kinase signaling mechanisms have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (ELONGATION FACTOR TU RECEPTOR) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1/SOMATIC EMBRYOGENESIS RECEPTOR KINASE 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.
format Online
Article
Text
id pubmed-10473708
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-104737082023-09-02 Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling Mühlenbeck, Henning Tsutsui, Yuko Lemmon, Mark A. Bender, Kyle W. Zipfel, Cyril bioRxiv Article Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic (pseudo)kinase signaling mechanisms have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (ELONGATION FACTOR TU RECEPTOR) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1/SOMATIC EMBRYOGENESIS RECEPTOR KINASE 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1. Cold Spring Harbor Laboratory 2023-08-24 /pmc/articles/PMC10473708/ /pubmed/37662281 http://dx.doi.org/10.1101/2023.08.23.554490 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Mühlenbeck, Henning
Tsutsui, Yuko
Lemmon, Mark A.
Bender, Kyle W.
Zipfel, Cyril
Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title_full Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title_fullStr Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title_full_unstemmed Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title_short Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
title_sort allosteric activation of the co-receptor bak1 by the efr receptor kinase initiates immune signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473708/
https://www.ncbi.nlm.nih.gov/pubmed/37662281
http://dx.doi.org/10.1101/2023.08.23.554490
work_keys_str_mv AT muhlenbeckhenning allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling
AT tsutsuiyuko allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling
AT lemmonmarka allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling
AT benderkylew allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling
AT zipfelcyril allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling